Teacher Retirement System of Texas grew its stake in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 20.4% in the ...
D. Boral Capital reaffirmed their buy rating on shares of ImmunityBio (NASDAQ:IBRX – Free Report) in a report issued on Monday,Benzinga reports. They currently have a $30.00 target price on the stock.
We recently published a list of 10 Stocks Outperform Broader Market Last Week. In this article, we are going to take a look ...